Long-Term Outcome of Patients with Complete Pathologic Response after Neoadjuvant Chemoradiation for cT3 Rectal Cancer: Implications for Local Excision Surgical Strategies

Long-Term Outcome of Patients with Complete Pathologic Response after Neoadjuvant Chemoradiation for cT3 Rectal Cancer: Implications for Local Excision Surgical Strategies

Bibliographic Details
Main Authors:	Belluco, Claudio, De Paoli, Antonino, Canzonieri, Vincenzo, Sigon, Roberto, Fornasarig, Mara, Buonadonna, Angela, Boz, Giovanni, Innocente, Roberto, Perin, Tiziana, Cossaro, Marta, Polesel, Jerry, De Marchi, Francesco
Format:	Online
Language:	English
Published:	Springer-Verlag 2011
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3222828/

Similar Items

Long-Term Outcome of Rectal Cancer With Clinically (EUS/MRI) Metastatic Mesorectal Lymph Nodes Treated by Neoadjuvant Chemoradiation: Role of Organ Preservation Strategies in Relation to Pathologic Response
by: Belluco, Claudio, et al.
Published: (2016)

Pharmacogenetics Biomarkers and Their Specific Role in Neoadjuvant Chemoradiotherapy Treatments: An Exploratory Study on Rectal Cancer Patients
by: Dreussi, Eva, et al.
Published: (2016)

Predictive role of microRNA-related genetic polymorphisms in the pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
by: Dreussi, Eva, et al.
Published: (2016)

MUC Gene Abnormalities in Sporadic and Hereditary Mucinous Colon Cancers with Microsatellite Instability
by: Pastrello, Chiara, et al.
Published: (2005)

Probe-based confocal laser endomicroscopy for in vivo evaluation of the tumor vasculature in gastric and rectal carcinomas
by: Paola Spessotto, et al.
Published: (2017-08-01)

Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer
by: Ferrari, Linda, et al.
Published: (2015)

Aspirin as a neoadjuvant agent during preoperative chemoradiation for rectal cancer
by: Restivo, Angelo, et al.
Published: (2015)

Neoadjuvant chemoradiation for rectal cancer in patients aged 75 years or older
by: Lombardi, Raffaele, et al.
Published: (2009)

Oncologic Impact of Fewer Than 12 Lymph Nodes in Patients Who Underwent Neoadjuvant Chemoradiation Followed by Total Mesorectal Excision for Locally Advanced Rectal Cancer
by: Kim, Woo Ram, et al.
Published: (2015)

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer
by: Habermehl, Daniel, et al.
Published: (2012)

A Predictive Genetic Signature for Response to Fluoropyrimidine-Based Neoadjuvant Chemoradiation in Clinical Stage II and III Rectal Cancer
by: Chan, Jason, et al.
Published: (2013)

Short–term effects of neoadjuvant chemoradiation therapy on anorectal function in rectal cancer patients: a pilot study
by: Kye, Bong-Hyeon, et al.
Published: (2013)

What does absence of lymph node in resected specimen mean after neoadjuvant chemoradiation for rectal cancer
by: Lee, Won-Suk, et al.
Published: (2013)

Low Mmp 9 and VEGF levels predict good oncologic outcome in mid and low rectal cancer patients with neoadjuvant chemoradiation
by: Kurt, Atilla, et al.
Published: (2012)

Optimal timing of surgery after neoadjuvant chemoradiation therapy in locally advanced rectal cancer
by: Jeong, Duck Hyoun, et al.
Published: (2013)

Outcome of neoadjuvant chemoradiation in MRI staged locally advanced rectal cancer: Retrospective analysis of 123 Chinese patients
by: Shing Fung Lee, et al.
Published: (2018-09-01)

Tumor regression in rectal cancer after intensified neoadjuvant chemoradiation: a morphometric and clinicopathological study
by: Prall, Friedrich, et al.
Published: (2015)

Focal adhesion kinase: predictor of tumour response and risk factor for recurrence after neoadjuvant chemoradiation in rectal cancer
by: Gómez del Pulgar, Teresa, et al.
Published: (2016)

Predictive value of vrk 1 and 2 for rectal adenocarcinoma response to neoadjuvant chemoradiation therapy: a retrospective observational cohort study
by: del Puerto-Nevado, Laura, et al.
Published: (2016)

Does Extending the Waiting Time of Low-Rectal Cancer Surgery after Neoadjuvant Chemoradiation Increase the Perioperative Complications?
by: Timudom, Kittinut, et al.
Published: (2016)

Cytokeratin 20 positive circulating tumor cells are a marker for response after neoadjuvant chemoradiation but not for prognosis in patients with rectal cancer
by: Hinz, Sebastian, et al.
Published: (2015)

Identification of Predictive Markers for Response to Neoadjuvant Chemoradiation in Rectal Carcinomas by Proteomic Isotope Coded Protein Label (ICPL) Analysis
by: Croner, Roland S., et al.
Published: (2016)

The prognostic significance of tumor epidermal growth factor receptor (EGFR) expression change after neoadjuvant chemoradiation in patients with rectal adenocarcinoma
by: Richter, Igor, et al.
Published: (2015)

Extramural depth of rectal cancer tumor invasion at thin-section MRI: predicting treatment response to neoadjuvant chemoradiation
by: Tong, Tong, et al.
Published: (2015)

Predictors of Pathologic Complete Response in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation
by: Han, Yoon Dae, et al.
Published: (2015)

Implications for selecting local excision in locally advanced rectal cancer after preoperative chemoradiation
by: Wan, Juefeng, et al.
Published: (2015)

Change of telomerase activity in rectal cancer with chemoradiation therapy.
by: Kim, H. R., et al.
Published: (2000)

Predictive Biomarkers to Chemoradiation in Locally Advanced Rectal Cancer
by: Conde-Muíño, Raquel, et al.
Published: (2015)

Manometric evaluation of anorectal function in patients treated with neoadjuvant chemoradiotherapy and total mesorectal excision for rectal cancer
by: De Nardi, Paola, et al.
Published: (2017)

Endomicroscopy and Cancer: A New Approach to the Visualization of Neoangiogenesis
by: Cannizzaro, Renato, et al.
Published: (2012)

Neoadjuvant chemoradiation therapy for borderline pancreatic adenocarcinoma: report of two cases
by: Galindo, José, et al.
Published: (2013)

Neoadjuvant Concurrent Chemoradiation for Curative Treatment of Penile Squamous Cell Carcinoma
by: Chhabra, Arpit, et al.
Published: (2014)

An effective multisource informed consent procedure for research and clinical practice: an observational study of patient understanding and awareness of their roles as research stakeholders in a cancer biobank
by: Cervo, Silvia, et al.
Published: (2013)

Neoadjuvant Treatment in Rectal Cancer: Actual Status
by: Garajová, Ingrid, et al.
Published: (2011)

Predictive Factors of the Response of Rectal Cancer to Neoadjuvant Radiochemotherapy
by: Spolverato, Gaya, et al.
Published: (2011)

Neoadjuvant chemoradiation compared to neoadjuvant radiation alone and surgery alone for Stage II and III soft tissue sarcoma of the extremities
by: Curtis, Kelly K, et al.
Published: (2011)

MRI Risk Stratification for Tumor Relapse in Rectal Cancer Achieving Pathological Complete Remission after Neoadjuvant Chemoradiation Therapy and Curative Resection
by: Kim, Honsoul, et al.
Published: (2016)

Consolidation chemotherapy during neoadjuvant chemoradiation (CRT) for distal rectal cancer leads to sustained decrease in tumor metabolism when compared to standard CRT regimen
by: Habr-Gama, Angelita, et al.
Published: (2016)

The use of personalized biomarkers and liquid biopsies to monitor treatment response and disease recurrence in locally advanced rectal cancer after neoadjuvant chemoradiation
by: Carpinetti, Paola, et al.
Published: (2015)

Baseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation
by: Shen, Lijun, et al.
Published: (2014)